SEARCH

SEARCH BY CITATION

References

  • Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B. (1994) Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 35:795801.
  • Appleton R, Fichtner K, LaMoreaux L, Alexander J, Halsall G, Murray G, Garofalo E, Gabapentin Paediatric Study Group. (1999) Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Epilepsia 40:11471154.
  • Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S, Pregabalin 1008-011 International Study Group. (2004) Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose–response study in adults with partial seizures. Epilepsia 45:2027.
  • Barcs G, Walker EB, Elger CE, Scaramelli A, Stefan H, Sturm Y, Moore A, Flesch G, Kramer L, DeSouza J. (2000) Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 41:15971607.
  • Bauer J, Dienel A, Elger CE, Losigamone Study Group. (2001) Losigamone add-on therapy in partial epilepsy: a placebo-controlled study. Acta Neurol Scand 103:226230.
  • Baulac M, Klement S, Losigamone Study Group. (2003) Efficacy and safety of Losigamone in partial seizures: a randomized double-blind study. Epilepsy Res 55:1771789.
  • Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M, Schmidt D, Ried S, Reife R, Kramer L, Pledger G, Karim R. (1996) Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 37:539543.
  • Ben-Menachem E, Falter U, European Levetiracetam Study Group. (2000) Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 41:12761283.
  • Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. (2007) Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48:13081317.
  • Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U, Levetiracetam N01057 Study Group. (2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69:17511760.
  • Betts T, Waegemans T, Crawford P. (2000) A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 9:8087.
  • Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA, Pregabalin 1008-009 Study Group. (2005) Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64:475480.
  • Birbeck GL, Hays RD, Cui X, Vickrey BG. (2002) Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 43:535538.
  • Biton V, Montouris GD, Ritter F, Riviello JJ, Reife R, Lim P, Pledger G. (1999) A randomized, placebo-controlled study of topiramate in primary generalized tonic–clonic seizures. Neurology 52:13301337.
  • Biton V, Sackellares JC, Vuong A, Hammer AE, Barrett PS, Messenheimer JA. (2005) Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 65:17371743.
  • Boon P, Chauvel P, Pohlmann-Eden B, Otoul C, Wroe S. (2002) Dose–response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy. Epilepsy Res 48:7789.
  • Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C. (2005) Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 46:3141.
  • Bruni J, Guberman A, Vachon L, Desforges C, The Canadian Vigabatrin Study Group. (2000) Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. Seizure 9:224232.
  • Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. (2005) Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55:236242.
  • Chapell R, Reston J, Snyder D (2003) Management of treatment-resistant epilepsy. Evidence report/technology assessment No.77. AHRQ Publication No.03-0028. Part 1. Agency for Healthcare Research and Quality, Rockville, MD, pp. 1323.
  • Chiron C, Dumas C, Jambaqué I, Mumford J, Dulac O. (1997) Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26:389395.
  • Dean C, Mosier M, Penry K. (1999) Dose–response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures. Epilepsia 40:7482.
  • DerSimonian R, Laird N. (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177188.
  • Duchowny M, Pellock JM, Graf WD, Billard C, Gilman J, Casale E, Womble G, Risner M, Manasco P. (1999) A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology 53:17241731.
  • Egger M, Davey-Smith G, Schneider M, Minder C. (1997) Bias in meta-analysis detected by a single, graphical test. BMJ 315:629634.
  • Elger CE, Brodie MJ, Anhut H, Lee CM, Barrett JA. (2005) Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 46:19261936.
  • Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P. (2007) Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 48:497504.
  • Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G. (1999) A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 52:13381344.
  • Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, Karim RM. (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 46:16841690.
  • Faught E, Ayala R, Montouris GG, Leppik IE, Zonisamide 922 Trial Group. (2001) Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 57:17741779.
  • Faught E. (2004) Treatment of refractory primary generalized epilepsy. Rev Neurol Dis 1(Suppl 1):S34S43.
  • French JA, Mosier M, Walker S, Sommerville K, Sussman N, Vigabatrin Protocol 024 Investigative Cohort. (1996) A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Neurology 46:5461.
  • French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA. (2003) Dose–response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60:16311637.
  • French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA, Therapeutics Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. (2004) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment. Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62:12611273.
  • Gazzola DM, Balcer LJ, French JA. (2007) Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 48:13031307.
  • Glauser TA, Nigro M, Sachdeo R, Psteris LAS, Weinstein S, Abou-Khalil B, Frank LM, Grinspan A, Guarino T, Bettis D, Kerrigan J, Geoffrey G, Mandelbaum D, Jacobs T, Mesenbrink P, Kramer L, D’Souza J. (2000) Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 54:22372244.
  • Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Oman CB, Gauer LJ, Lu Z, N159 Study Group. (2006) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66:16541660.
  • Grant R, Shorvon SD. (2000) Efficacy and tolerability of 1000–4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy. Epilepsy Res 42:8995.
  • Higgins JPT, Thompson SG, Decks JJ. (2003) Measuring inconsistency in meta-analyses. Brit Med J 327:557560.
  • Higgins JT, Higgins JPT. (2008) Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37:11581160.
  • Kälviäinen R, Brodie MJ, Duncan J, Chadwick D, Edwards D, Lyby K. (1998) A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Epilepsy Res 30:3140.
  • Kerr MP, Baker GA, Brodie MJ. (2005) A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Epilepsy Behav 7:472480.
  • Korean Topiramate Study Group. (1999) Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Epilepsia 40:17671774.
  • Kwan P, Brodie MJ. (2000) Early identification of refractory epilepsy. N Engl J Med 342:314319.
  • Löscher W, Schmidt D. (2006) New Horizons in the development of antiepileptic drugs: innovative strategies. Epilepsy Res 69:183272.
  • Luciano AL, Shorvon SD. (2007) Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 62:375381.
  • Maguire MJ, Hemming K, Hutton JL, Marson AG. (2008) Overwhelming heterogeneity in systematic reviews of observational anti-epileptic drugs. Epilepsy Res 80:201212.
  • Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, Lineberry CG. (1993) Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 43:22842291.
  • Messenheimer J, Ramsay RE, Willmore LJ, Leroy RF, Zielinski JJ, Mattson R, Pellock JM, Valakas AM, Womble G, Risner M. (1994) Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 35:113121.
  • Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. (1997) Lamotrigine for generalized seizures associated with the Lennox–Gastaut syndrome. N Engl J Med 337:18071812.
  • Naritoku DK, Warnock CR, Messenheimer JA, Borgohain R, Evers S, Guekht AB, Karlov VA, Lee BI, Pohl LR. (2007) Lamotrigine extended-release as adjunctive therapy for partial seizures. Neurology 69:16101618.
  • Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J, N 166 Levetiracetam Study Group. (2008) Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 70:607616.
  • Oken BS. (2008) Placebo effects: clinical aspects and neurobiology. Brain 131:28122823.
  • Pålhagen S, Canger R, Henriksen O, Van Parys JA, Riviere ME, Karolchyk MA. (2001) Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy. Epilepsy Res 43:1151124.
  • Porter RJ, Partiot A, Sachdeo R, Nohria V, Alves WM, 205 Study Group. (2007) Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 68:11971204.
  • Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim G. (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology 46:16781683.
  • Rheims S, Cucherat M, Arzimanoglou A, Ryvlin P. (2008) Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med 5:e166.
  • Sachdeo RC, Leroy RF, Krauss GL, Drake Me Jr, Green PM, Leppik IE, Shu VS, Ringham GL, Sommerville KW. (1997) Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group. Arch Neurol 54:595601.
  • Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. (1999) A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome. Neurology 52:18821887.
  • Sackellares JC, Ramsay RE, Wilder BJ, Browne TR III, Shellenberger MK. (2004) Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 45:610617.
  • Schiller Y, Najjar Y. (2008) Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 70:5465.
  • Schmidt D, Jacob R, Loiseau P, Deisenhammer E, Klinger D, Despland A, Egli M, Bauer G, Stenzel E, Blankenhorn V. (1993) Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 15:6773.
  • Schmidt D, Löscher W. (2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46:858877.
  • Selwa LM, Schmidt SL, Malow BA, Beydoun A. (2003) Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy. Epilepsia 44:15681572.
  • Sharief M, Viteri C, Ben-Menachem E, Weber M, Reife R, Pledger G, Karim R. (1996) Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 25:217224.
  • Shorvon SD, Löwenthal A, Janz D, Bielen E, Loiseau P. (2000) Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 41:11791186.
  • Sillanpää M, Schmidt D. (2006) Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 61:724.
  • Tassinari CA, Michelucci R, Chauvel P, Chodkiewicz J, Shorvon S, Henriksen O, Dam M, Reife R, Pledger G, Karim R. (1996) Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 37:763768.
  • The US Gabapentin Study Group No. 5. (1993) Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 43:22922298.
  • Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA. (2006) Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic–clonic seizures. Pediatrics 118:e371e378.
  • Tsai JJ, Yen DJ, Hsih MS, Chen SS, Hiersemenzel R, Edrich P, Lai CW. (2006) Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study. Epilepsia 47:7281.
  • UK Gabapentin Study Group. (1990) Gabapentin in partial epilepsy. Lancet 335:11141117.
  • Uthman BM, Rowan AJ, Ahmann PA, Leppik JE, Schachter SC, Sommerville KW, Shu V. (1998) Tiagabine for complex partial seizures: a randomized, add-on, dose–response trial. Arch Neurol 55:5662.
  • Yamauchi T, Kaneko S, Yagi K, Sase S. (2006) Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study. Psychiatry Clin Neurosci 60:507515.
  • Yen DJ, Yu HY, Guo YC, Chen C, Yiu CH, Su MS. (2000) A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy. Epilepsia 41:11621166.